238 related articles for article (PubMed ID: 26905963)
1. Intravesical radiofrequency-induced hyperthermia combined with chemotherapy for non-muscle-invasive bladder cancer.
van Valenberg H; Colombo R; Witjes F
Int J Hyperthermia; 2016 Jun; 32(4):351-62. PubMed ID: 26905963
[TBL] [Abstract][Full Text] [Related]
2. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.
Arends TJ; Nativ O; Maffezzini M; de Cobelli O; Canepa G; Verweij F; Moskovitz B; van der Heijden AG; Witjes JA
Eur Urol; 2016 Jun; 69(6):1046-52. PubMed ID: 26803476
[TBL] [Abstract][Full Text] [Related]
3. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.
Lammers RJ; Witjes JA; Inman BA; Leibovitch I; Laufer M; Nativ O; Colombo R
Eur Urol; 2011 Jul; 60(1):81-93. PubMed ID: 21531502
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency-induced thermo-chemotherapy effect (RITE) for non muscle invasive bladder cancer treatment: current role and perspectives.
Colombo R; van Valenberg H; Moschini M; Witjes JA
Urologia; 2016 Oct; 83(Suppl 2):7-17. PubMed ID: 27768213
[TBL] [Abstract][Full Text] [Related]
5. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations.
Liem EI; Crezee H; de la Rosette JJ; de Reijke TM
Int J Hyperthermia; 2016 Jun; 32(4):363-73. PubMed ID: 27056069
[TBL] [Abstract][Full Text] [Related]
6. Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.
van Valenberg FJP; van der Heijden AG; Lammers RJM; Falke J; Arends TJH; Oosterwijk E; Witjes JA
Int J Hyperthermia; 2018 Nov; 34(7):988-993. PubMed ID: 29191126
[TBL] [Abstract][Full Text] [Related]
7. [Intravesical instillations in non-muscle-invasive bladder cancer (NMIBC). Prospects for thermochemotherapy].
Irani J
Prog Urol; 2016 Nov; 26(14):860-864. PubMed ID: 27712914
[TBL] [Abstract][Full Text] [Related]
8. The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
Bahouth Z; Halachmi S; Moskovitz B; Nativ O
Expert Rev Anticancer Ther; 2016; 16(2):189-98. PubMed ID: 26618756
[TBL] [Abstract][Full Text] [Related]
9. [Chemohyperthermia using MMC in non-muscle-invasive bladder cancer: Current status and future perspectives.].
Coenen JJMJH; van Valenberg FJP; Arends TJH; Witjes JA
Arch Esp Urol; 2018 May; 71(4):400-408. PubMed ID: 29745929
[TBL] [Abstract][Full Text] [Related]
10. [Role of the combined regimen with local chemotherapy and Mw-induced hyperthermia for non-muscle invasive bladder cancer management. A systematic review].
Colombo R; Moschini M
Urologia; 2013; 80(2):112-9. PubMed ID: 23852928
[TBL] [Abstract][Full Text] [Related]
11. Device-assisted intravesical therapy for non-muscle invasive bladder cancer.
Hendricksen K
Transl Androl Urol; 2019 Feb; 8(1):94-100. PubMed ID: 30976573
[TBL] [Abstract][Full Text] [Related]
12. The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer.
Slater SE; Patel P; Viney R; Foster M; Porfiri E; James ND; Montgomery B; Bryan RT
Ann R Coll Surg Engl; 2014 Sep; 96(6):415-9. PubMed ID: 25198970
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia.
González-Padilla DA; González-Díaz A; Guerrero-Ramos F; Rodríguez-Serrano A; García-Jarabo E; Corona-laPuerta M; Rodríguez-Antolín A; Villacampa-Aubá F
Urol Oncol; 2021 Jan; 39(1):76.e9-76.e14. PubMed ID: 32753359
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial.
Tan WS; Prendergast A; Ackerman C; Yogeswaran Y; Cresswell J; Mariappan P; Phull J; Hunter-Campbell P; Lazarowicz H; Mishra V; Rane A; Davies M; Warburton H; Cooke P; Mostafid H; Wilby D; Mills R; Issa R; Kelly JD
Eur Urol; 2023 Jun; 83(6):497-504. PubMed ID: 35999119
[TBL] [Abstract][Full Text] [Related]
15. Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
Zhao H; Chan VW; Castellani D; Chan EO; Ong WLK; Peng Q; Moschini M; Krajewski W; Pradere B; Ng CF; Enikeev D; Vasdev N; Ekin G; Sousa A; Leon J; Guerrero-Ramos F; Tan WS; Kelly J; Shariat SF; Witjes JA; Teoh JY
Front Surg; 2021; 8():775527. PubMed ID: 34888347
[No Abstract] [Full Text] [Related]
16. Analysis of tolerance and security of chemo hyperthermia with Mitomycin C for the treatment of non-muscle invasive bladder cancer.
León-Mata J; Domínguez JL; Redorta JP; Sousa González D; Alvarez Casal M; Sousa Escandón A; Piñeiro Vázquez E
Arch Esp Urol; 2018 May; 71(4):426-437. PubMed ID: 29745932
[TBL] [Abstract][Full Text] [Related]
17. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.
Malmström PU; Sylvester RJ; Crawford DE; Friedrich M; Krege S; Rintala E; Solsona E; Di Stasi SM; Witjes JA
Eur Urol; 2009 Aug; 56(2):247-56. PubMed ID: 19409692
[TBL] [Abstract][Full Text] [Related]
18. A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer.
Ruan Q; Ding D; Wang B; He C; Ren X; Feng Z; Pang Z; Wang J; Zhang X; Tang H; Wang J; He Q; Lei Z; Liao Q; Luo J; Cui S
Cancer Biol Med; 2021 Feb; 18(1):308-317. PubMed ID: 33628603
[TBL] [Abstract][Full Text] [Related]
19. Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
Turker P; Turkeri L
Arch Esp Urol; 2013 Nov; 66(9):833-40. PubMed ID: 24231293
[TBL] [Abstract][Full Text] [Related]
20. Intravesical Chemotherapy and Chemohyperthermia in Non-Muscle-Invasive Bladder Cancer; An Overview on Drug Administration Technologies and Pharmacokinetics.
Campodonico F; Di Stasi S; Lev GM; Terrone C; Bongiovanni L; Mattioli F; Pagliarulo V; Introini C
Curr Drug Metab; 2017; 18(7):657-665. PubMed ID: 28460622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
